UK committee calls for wider access to ‘unlicensed’ medical cannabis

September 10, 2023 · MJ Biz Daily

The United Kingdom’s Home Affairs Committee is recommending the government widen access to unlicensed cannabis-based products for medical use via the National Health Service before the end of the current Parliament.

The National Health Service (NHS) is England’s publicly funded health care system.

The government has two months to respond to the committee’s recommendation.

There are currently no licensed cannabis-based products for medical use (CBPMs) in the U.K.

And, though unlicensed CBPMs may be prescribed, none have received marketing authorization. (Epidyolex – the trade name in Europe for Epidiolex – nabilone and Sativex are considered licensed cannabis-based medicines but not CBPMs.)

“We are concerned that there is currently a lack of access on the (NHS) for patients with a genuine medical need. Access continues to be a problem,” the committee’s report noted.

Earlier this year, the U.K. disclosed that fewer than five patients received unlicensed cannabis-based medicine from England’s publicly funded health care system.

However, 89,239 unlicensed medical cannabis “items” were prescribed to patients through the private sector – meaning patients pay out of pocket – between November 2018 and July 2022.

In 2018, the U.K. rescheduled marijuana from Schedule 1 to Schedule 2, a move that allowed specialist clinicians to prescribe medical cannabis. The specialists can work in the NHS or privately.

In its report, the Home Affairs Committee said it supports cannabis-based products for medical use “where there is an evidence base that it can be an effective form of treatment for managing conditions or symptoms.”

The committee acknowledged evidence of the potential therapeutic value of medical cannabis in treating chronic pain.

The committee’s report recommended that “the Government supports researchers to conduct (randomized) control trials into the effectiveness of CBPMs to treat chronic pain.”

“If the evidence base supports this, and it is deemed to be cost-effective, we recommend that the Government enables the use of CBPMs for this purpose and works with clinicians to ensure that it is a treatment option in appropriate cases.”

The committee noted its concern about recreational cannabis.

“We are concerned by the harms that cannabis for non-medical use may pose, particularly in relation to young people,” the committee said in the report.

“We do not believe that cannabis should be (legalized) and regulated for non-medical use.”

Separately, in the same report, the committee welcomed the U.K. government’s commitment to reducing barriers to researching psychedelic drugs.

However, the committee recommended the U.K. government “urgently moves psychedelic drugs to Schedule 2 in order to facilitate research on the medical or therapeutic value of these drugs.” (Full Story)

In categories:International Medical
Next Post

Canadian Takeover of High Times Puts Company in the Hands of Discredited CEO

High Times has been sold to Victoria, BC-based psychedelics firm Lucy Scientific Discovery (for LSD) headed by disgraced Hollywood executive Richard Nanula. The news leaked out yesterday with a press release sent to a handful of media sources: Lucy Scientific Discovery Inc.…
Previous Post

The International Cannabis Trade is Booming without the US - Guess Which Countries are Buying and Importing the Most Weed?

According to recently released data from Health Canada to MJBizDaily, Canada's medical cannabis exporters found their most significant markets in Australia and Israel last year. During the fiscal year from April 2022 to March 2023, Canada shipped 59,986 kilograms (approximately…
Random Post

California Lawmaker Revives Bill To Legalize Marijuana Cafes Months After Governor’s Veto

A California lawmaker is renewing his push to legalize cannabis cafes in the state, with a newly introduced bill and plans to work with the governor and regulators to address concerns that resulted in the last version being vetoed. Assemblymember Matt…
Random Post

University of Utah Health Launches Center for Medical Cannabis Research

The University of Utah Health is partnering with the state to launch the Center for Medical Cannabis Research (CMCR) which aims to “advance scientific understanding of medical cannabis and help patients and providers make informed health decisions about this increasingly…
Random Post

Opinion: 4 signs your cannabis customer is not going to pay you

If you have been paying attention to the California cannabis market recently, you have heard about the credit crisis many suppliers are dealing with. Not only do marijuana-related operators in the state owe more than $250 million in unpaid taxes – a primary reason…
Random Post

You Can Now Buy Weed Online in Colorado, A Trend for the Industry?

Colorado Governor Jared Polis passed a ground-breaking law allowing the sale of marijuana products online. After a month of consideration, this landmark decision ushers in a new era for the state's cannabis business. By embracing e-commerce, Colorado joins other progressive states…